Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Mucositis 2Inflammation 2Diarrhea 2Chalazion 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Smoldering Multiple Myeloma 1Radiation Injuries 1Pelvic Neoplasms 1Pelvic Inflammatory Disease 1Neoplasms, Second Primary 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Malnutrition 1Liver Cirrhosis 1Laryngeal Neoplasms 1Infections 1Generalized Anxiety Disorder 1Fibrosis 1Fatigue Syndrome, Chronic 1Enteritis 1Endotoxemia 1Carcinogenesis 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × Probiotics × Clear all
NCT07607548 2026-05-26

Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer

Poznan University of Medical Sciences

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Inflammation

NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
308 enrolled
Breast

Breast Neoplasms, Diarrhea

NCT03358511 2020-05-21

Engineering Gut Microbiome to Target Breast Cancer

Mayo Clinic

Phase NA Completed
7 enrolled
Breast

Breast Neoplasms

NCT01723592 2017-06-06

Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.

Medical University of Vienna

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡